Text Size

The North American Pancreatitis Study (NAPS)

This study is currently recruiting participants.
Verified February 2012 by University of Pittsburgh
Sponsor:
Information provided by (Responsible Party):
University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT01545167
First received: February 29, 2012
Last updated: NA
Last verified: February 2012
History: No changes posted
  Purpose

This study will investigate several genes and other factors measured in the blood that may cause recurrent acute pancreatitis and chronic pancreatitis.


Condition Intervention
Pancreatitis
 Genetic: blood sampling
Other: questionnaire

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: The North American Pancreatitis Study

Resource links provided by NLM:

MedlinePlus related topics: Pancreatitis
U.S. FDA Resources

Further study details as provided by University of Pittsburgh:

Biospecimen Retention:   Samples With DNA

Blood samples and extracted biomarkers and genetic material.


Estimated Enrollment: 4800
Study Start Date: September 2008
Groups/Cohorts Assigned Interventions
pancreatitis
pancreatitis
 Genetic: blood sampling
blood samples obtained to extract biomarkers and dna for analysis
Other: questionnaire
questionnaire
controls
people without pancreatitis
 Genetic: blood sampling
blood samples obtained to extract biomarkers and dna for analysis
Other: questionnaire
questionnaire

Detailed Description:

This study seeks to enroll people with and without pancreatitis. There is only one study visit to obtain consent, a blood sample and complete a questionnaire.

  Eligibility

Ages Eligible for Study:   14 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

people with and without pancreatitis

Criteria

Inclusion Criteria:

pancreatitis patients who are at least 14 years of age with a diagnosis of acute or chronic pancreatits

  • controls who do not have pancreatitis and must be at least 18 years of age

Exclusion Criteria:

  • unable or unwilling to sign informed consent
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01545167

Contacts
Contact: Megan Hendricks, RN meganh@pitt.edu

Locations
United States, Pennsylvania
University of Pittsburgh Recruiting
Pittsburgh, Pennsylvania, United States, 15213
Contact: Megan Hendricks, RN         meganh@pitt.edu    
Principal Investigator: David Whitcomb, MD, PhD            
Sponsors and Collaborators
University of Pittsburgh
  More Information

No publications provided

Responsible Party: University of Pittsburgh
ClinicalTrials.gov Identifier: NCT01545167     History of Changes
Other Study ID Numbers: DK 061451, NAPS2-AS
Study First Received: February 29, 2012
Last Updated: February 29, 2012
Health Authority: United States: Institutional Review Board

Keywords provided by University of Pittsburgh:
pancreatits

Additional relevant MeSH terms:
Pancreatitis
Pancreatic Diseases
Digestive System Diseases

ClinicalTrials.gov processed this record on May 16, 2013